Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)

Guenter Auerswald,1 Claudia Djambas Khayat,2 Oleksandra Stasyshyn,3 Genadi Iosava,4 Irina Romashevskaya,5 Marta Julia López,6 Wilfried Seifert,7 Tobias Rogosch7 1Hess Kinderklinik, Klinikum Bremen-Mitte, Bremen, Germany; 2Hotel Dieu de France Hospital, St Joseph University, Beirut, Lebano...

Full description

Bibliographic Details
Main Authors: Auerswald G, Djambas Khayat C, Stasyshyn O, Iosava G, Romashevskaya I, López MJ, Seifert W, Rogosch T
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Journal of Blood Medicine
Subjects:
von willebrand disease
clinical trial
pediatrics
prophylaxis
von willebrand factor-factor viii concentrate
Online Access:https://www.dovepress.com/pharmacokinetics-efficacy-and-safety-of-a-plasma-derived-vwffviii-conc-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/pharmacokinetics-efficacy-and-safety-of-a-plasma-derived-vwffviii-conc-peer-reviewed-article-JBM

Similar Items